2022. The assessment of Cyclophosphamide Chemotherapy Effect Loading-PLGA Nanoparticles Against Ovarian Cancer Cells Line (OVCAR-4 and PEO1). Journal of Pharmaceutical Negative Results. 13, 1 (Jan. 2022), 39–43.